カテゴリ： 世界, 医療/バイオ, QYResearch

内視鏡逆行性胆道膵管造影（ERCP）技術の世界市場インサイト・予測（～2028年）

■ 英語タイトル：Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Insights, Forecast to 2028

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QY22JL3555）■ 発行会社/調査会社：QYResearch
■ 商品コード：QY22JL3555
■ 発行日：2022年7月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：125
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[内視鏡逆行性胆道膵管造影（ERCP）技術の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

COVID-19のパンデミックにより、内視鏡逆行性胆道膵管造影（ERCP）技術のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に内視鏡逆行性胆道膵管造影（ERCP）技術の世界市場のxxx％を占める「内視鏡」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
内視鏡逆行性胆道膵管造影（ERCP）技術の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの内視鏡逆行性胆道膵管造影（ERCP）技術市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

内視鏡逆行性胆道膵管造影（ERCP）技術のグローバル主要企業には、Olympus Corporation、CONMED Corporation、Fujifilm Holdings Corporation、HOYA Corporation、KARL STORZ SE & Co. KG、Ambu A/S、Boston Scientific Corporation、Johnson & Johnson、Medtronic, PLC、Cook Medical、B. Braun Melsungen AG、Hobbs Medical, Inc.、STERIS PLC、Merit Medical Systems, Inc.、TeleMed Systems, Inc.、Changzhou Health Microport Medical Device Co., LTD.、Medi-Globe GmbH、Taewoong Medical Co., Ltd.、Huger Medical Instrument Co., Ltd.、IntroMedic Co., Ltd.、SonoScape Medical Corporation、Shanghai AOHUA Photoelectricity Endoscope Co., Ltd.、Ottomed、Kimberly-Clark Corporation、Shaili Endoscopyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

内視鏡逆行性胆道膵管造影（ERCP）技術市場は、種類と用途によって区分されます。世界の内視鏡逆行性胆道膵管造影（ERCP）技術市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
内視鏡、内視鏡装置、視覚化システム、エネルギー装置、その他

【用途別セグメント】
病院、外来手術センター＆クリニック、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 内視鏡逆行性胆道膵管造影（ERCP）技術製品概要
- 種類別市場（内視鏡、内視鏡装置、視覚化システム、エネルギー装置、その他）
- 用途別市場（病院、外来手術センター＆クリニック、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の内視鏡逆行性胆道膵管造影（ERCP）技術販売量予測2017-2028
- 世界の内視鏡逆行性胆道膵管造影（ERCP）技術売上予測2017-2028
- 内視鏡逆行性胆道膵管造影（ERCP）技術の地域別販売量
- 内視鏡逆行性胆道膵管造影（ERCP）技術の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別内視鏡逆行性胆道膵管造影（ERCP）技術販売量
- 主要メーカー別内視鏡逆行性胆道膵管造影（ERCP）技術売上
- 主要メーカー別内視鏡逆行性胆道膵管造影（ERCP）技術価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（内視鏡、内視鏡装置、視覚化システム、エネルギー装置、その他）
- 内視鏡逆行性胆道膵管造影（ERCP）技術の種類別販売量
- 内視鏡逆行性胆道膵管造影（ERCP）技術の種類別売上
- 内視鏡逆行性胆道膵管造影（ERCP）技術の種類別価格
・用途別市場規模（病院、外来手術センター＆クリニック、その他）
- 内視鏡逆行性胆道膵管造影（ERCP）技術の用途別販売量
- 内視鏡逆行性胆道膵管造影（ERCP）技術の用途別売上
- 内視鏡逆行性胆道膵管造影（ERCP）技術の用途別価格
・北米市場
- 北米の内視鏡逆行性胆道膵管造影（ERCP）技術市場規模（種類別、用途別）
- 主要国別の内視鏡逆行性胆道膵管造影（ERCP）技術市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの内視鏡逆行性胆道膵管造影（ERCP）技術市場規模（種類別、用途別）
- 主要国別の内視鏡逆行性胆道膵管造影（ERCP）技術市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の内視鏡逆行性胆道膵管造影（ERCP）技術市場規模（種類別、用途別）
- 主要国別の内視鏡逆行性胆道膵管造影（ERCP）技術市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の内視鏡逆行性胆道膵管造影（ERCP）技術市場規模（種類別、用途別）
- 主要国別の内視鏡逆行性胆道膵管造影（ERCP）技術市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの内視鏡逆行性胆道膵管造影（ERCP）技術市場規模（種類別、用途別）
- 主要国別の内視鏡逆行性胆道膵管造影（ERCP）技術市場規模（トルコ、サウジアラビア）
・企業情報
Olympus Corporation、CONMED Corporation、Fujifilm Holdings Corporation、HOYA Corporation、KARL STORZ SE & Co. KG、Ambu A/S、Boston Scientific Corporation、Johnson & Johnson、Medtronic, PLC、Cook Medical、B. Braun Melsungen AG、Hobbs Medical, Inc.、STERIS PLC、Merit Medical Systems, Inc.、TeleMed Systems, Inc.、Changzhou Health Microport Medical Device Co., LTD.、Medi-Globe GmbH、Taewoong Medical Co., Ltd.、Huger Medical Instrument Co., Ltd.、IntroMedic Co., Ltd.、SonoScape Medical Corporation、Shanghai AOHUA Photoelectricity Endoscope Co., Ltd.、Ottomed、Kimberly-Clark Corporation、Shaili Endoscopy
・産業チェーン及び販売チャネル分析
- 内視鏡逆行性胆道膵管造影（ERCP）技術の産業チェーン分析
- 内視鏡逆行性胆道膵管造影（ERCP）技術の原材料
- 内視鏡逆行性胆道膵管造影（ERCP）技術の生産プロセス
- 内視鏡逆行性胆道膵管造影（ERCP）技術の販売及びマーケティング
- 内視鏡逆行性胆道膵管造影（ERCP）技術の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 内視鏡逆行性胆道膵管造影（ERCP）技術の産業動向
- 内視鏡逆行性胆道膵管造影（ERCP）技術のマーケットドライバー
- 内視鏡逆行性胆道膵管造影（ERCP）技術の課題
- 内視鏡逆行性胆道膵管造影（ERCP）技術の阻害要因
・主な調査結果

Endoscopic retrograde cholangiopancreatography (ERCP) is a procedure that combines upper gastrointestinal (GI) endoscopy and x-rays to treat problems of the bile and pancreatic ducts.
Market Analysis and Insights: Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market
The global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Endoscopes accounting for % of the Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique market size is valued at US$ million in 2021, while the North America and Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique market.
Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Scope and Market Size
Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Endoscopes
Endotherapy Devices
Visualization Systems
Energy Devices
Others
Segment by Application
Hospitals
Ambulatory Surgery Centres & Clinics
Other
By Company
Olympus Corporation
CONMED Corporation
Fujifilm Holdings Corporation
HOYA Corporation
KARL STORZ SE & Co. KG
Ambu A/S
Boston Scientific Corporation
Johnson & Johnson
Medtronic, PLC
Cook Medical
B. Braun Melsungen AG
Hobbs Medical, Inc.
STERIS PLC
Merit Medical Systems, Inc.
TeleMed Systems, Inc.
Changzhou Health Microport Medical Device Co., LTD.
Medi-Globe GmbH
Taewoong Medical Co., Ltd.
Huger Medical Instrument Co., Ltd.
IntroMedic Co., Ltd.
SonoScape Medical Corporation
Shanghai AOHUA Photoelectricity Endoscope Co., Ltd.
Ottomed
Kimberly-Clark Corporation
Shaili Endoscopy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

*** レポート目次（コンテンツ）***

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Endoscopes
1.2.3 Endotherapy Devices
1.2.4 Visualization Systems
1.2.5 Energy Devices
1.2.6 Others
1.3 Market by Application
1.3.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgery Centres & Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Perspective (2017-2028)
2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Growth Trends by Region
2.2.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Historic Market Size by Region (2017-2022)
2.2.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Forecasted Market Size by Region (2023-2028)
2.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Dynamics
2.3.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Industry Trends
2.3.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Drivers
2.3.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Challenges
2.3.4 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Players by Revenue
3.1.1 Global Top Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Players by Revenue (2017-2022)
3.1.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue Market Share by Players (2017-2022)
3.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue
3.4 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Concentration Ratio
3.4.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Revenue in 2021
3.5 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Key Players Head office and Area Served
3.6 Key Players Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Product Solution and Service
3.7 Date of Enter into Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Breakdown Data by Type
4.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Historic Market Size by Type (2017-2022)
4.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Forecasted Market Size by Type (2023-2028)
5 Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Breakdown Data by Application
5.1 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Historic Market Size by Application (2017-2022)
5.2 Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size (2017-2028)
6.2 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type
6.2.1 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type (2017-2022)
6.2.2 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type (2023-2028)
6.2.3 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Share by Type (2017-2028)
6.3 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application
6.3.1 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application (2017-2022)
6.3.2 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application (2023-2028)
6.3.3 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Share by Application (2017-2028)
6.4 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country
6.4.1 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country (2017-2022)
6.4.2 North America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size (2017-2028)
7.2 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type
7.2.1 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type (2017-2022)
7.2.2 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type (2023-2028)
7.2.3 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Share by Type (2017-2028)
7.3 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application
7.3.1 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application (2017-2022)
7.3.2 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application (2023-2028)
7.3.3 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Share by Application (2017-2028)
7.4 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country
7.4.1 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country (2017-2022)
7.4.2 Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size (2017-2028)
8.2 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type
8.2.1 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Share by Type (2017-2028)
8.3 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application
8.3.1 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Share by Application (2017-2028)
8.4 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Region
8.4.1 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size (2017-2028)
9.2 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type
9.2.1 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type (2017-2022)
9.2.2 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type (2023-2028)
9.2.3 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Share by Type (2017-2028)
9.3 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application
9.3.1 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application (2017-2022)
9.3.2 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application (2023-2028)
9.3.3 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Share by Application (2017-2028)
9.4 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country
9.4.1 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country (2017-2022)
9.4.2 Latin America Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size (2017-2028)
10.2 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type
10.2.1 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Share by Type (2017-2028)
10.3 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application
10.3.1 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Share by Application (2017-2028)
10.4 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country
10.4.1 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Olympus Corporation
11.1.1 Olympus Corporation Company Details
11.1.2 Olympus Corporation Business Overview
11.1.3 Olympus Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.1.4 Olympus Corporation Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.1.5 Olympus Corporation Recent Developments
11.2 CONMED Corporation
11.2.1 CONMED Corporation Company Details
11.2.2 CONMED Corporation Business Overview
11.2.3 CONMED Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.2.4 CONMED Corporation Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.2.5 CONMED Corporation Recent Developments
11.3 Fujifilm Holdings Corporation
11.3.1 Fujifilm Holdings Corporation Company Details
11.3.2 Fujifilm Holdings Corporation Business Overview
11.3.3 Fujifilm Holdings Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.3.4 Fujifilm Holdings Corporation Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.3.5 Fujifilm Holdings Corporation Recent Developments
11.4 HOYA Corporation
11.4.1 HOYA Corporation Company Details
11.4.2 HOYA Corporation Business Overview
11.4.3 HOYA Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.4.4 HOYA Corporation Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.4.5 HOYA Corporation Recent Developments
11.5 KARL STORZ SE & Co. KG
11.5.1 KARL STORZ SE & Co. KG Company Details
11.5.2 KARL STORZ SE & Co. KG Business Overview
11.5.3 KARL STORZ SE & Co. KG Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.5.4 KARL STORZ SE & Co. KG Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.5.5 KARL STORZ SE & Co. KG Recent Developments
11.6 Ambu A/S
11.6.1 Ambu A/S Company Details
11.6.2 Ambu A/S Business Overview
11.6.3 Ambu A/S Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.6.4 Ambu A/S Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.6.5 Ambu A/S Recent Developments
11.7 Boston Scientific Corporation
11.7.1 Boston Scientific Corporation Company Details
11.7.2 Boston Scientific Corporation Business Overview
11.7.3 Boston Scientific Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.7.4 Boston Scientific Corporation Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.7.5 Boston Scientific Corporation Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.8.4 Johnson & Johnson Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.8.5 Johnson & Johnson Recent Developments
11.9 Medtronic, PLC
11.9.1 Medtronic, PLC Company Details
11.9.2 Medtronic, PLC Business Overview
11.9.3 Medtronic, PLC Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.9.4 Medtronic, PLC Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.9.5 Medtronic, PLC Recent Developments
11.10 Cook Medical
11.10.1 Cook Medical Company Details
11.10.2 Cook Medical Business Overview
11.10.3 Cook Medical Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.10.4 Cook Medical Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.10.5 Cook Medical Recent Developments
11.11 B. Braun Melsungen AG
11.11.1 B. Braun Melsungen AG Company Details
11.11.2 B. Braun Melsungen AG Business Overview
11.11.3 B. Braun Melsungen AG Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.11.4 B. Braun Melsungen AG Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.11.5 B. Braun Melsungen AG Recent Developments
11.12 Hobbs Medical, Inc.
11.12.1 Hobbs Medical, Inc. Company Details
11.12.2 Hobbs Medical, Inc. Business Overview
11.12.3 Hobbs Medical, Inc. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.12.4 Hobbs Medical, Inc. Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.12.5 Hobbs Medical, Inc. Recent Developments
11.13 STERIS PLC
11.13.1 STERIS PLC Company Details
11.13.2 STERIS PLC Business Overview
11.13.3 STERIS PLC Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.13.4 STERIS PLC Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.13.5 STERIS PLC Recent Developments
11.14 Merit Medical Systems, Inc.
11.14.1 Merit Medical Systems, Inc. Company Details
11.14.2 Merit Medical Systems, Inc. Business Overview
11.14.3 Merit Medical Systems, Inc. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.14.4 Merit Medical Systems, Inc. Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.14.5 Merit Medical Systems, Inc. Recent Developments
11.15 TeleMed Systems, Inc.
11.15.1 TeleMed Systems, Inc. Company Details
11.15.2 TeleMed Systems, Inc. Business Overview
11.15.3 TeleMed Systems, Inc. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.15.4 TeleMed Systems, Inc. Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.15.5 TeleMed Systems, Inc. Recent Developments
11.16 Changzhou Health Microport Medical Device Co., LTD.
11.16.1 Changzhou Health Microport Medical Device Co., LTD. Company Details
11.16.2 Changzhou Health Microport Medical Device Co., LTD. Business Overview
11.16.3 Changzhou Health Microport Medical Device Co., LTD. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.16.4 Changzhou Health Microport Medical Device Co., LTD. Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.16.5 Changzhou Health Microport Medical Device Co., LTD. Recent Developments
11.17 Medi-Globe GmbH
11.17.1 Medi-Globe GmbH Company Details
11.17.2 Medi-Globe GmbH Business Overview
11.17.3 Medi-Globe GmbH Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.17.4 Medi-Globe GmbH Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.17.5 Medi-Globe GmbH Recent Developments
11.18 Taewoong Medical Co., Ltd.
11.18.1 Taewoong Medical Co., Ltd. Company Details
11.18.2 Taewoong Medical Co., Ltd. Business Overview
11.18.3 Taewoong Medical Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.18.4 Taewoong Medical Co., Ltd. Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.18.5 Taewoong Medical Co., Ltd. Recent Developments
11.19 Huger Medical Instrument Co., Ltd.
11.19.1 Huger Medical Instrument Co., Ltd. Company Details
11.19.2 Huger Medical Instrument Co., Ltd. Business Overview
11.19.3 Huger Medical Instrument Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.19.4 Huger Medical Instrument Co., Ltd. Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.19.5 Huger Medical Instrument Co., Ltd. Recent Developments
11.20 IntroMedic Co., Ltd.
11.20.1 IntroMedic Co., Ltd. Company Details
11.20.2 IntroMedic Co., Ltd. Business Overview
11.20.3 IntroMedic Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.20.4 IntroMedic Co., Ltd. Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.20.5 IntroMedic Co., Ltd. Recent Developments
11.21 SonoScape Medical Corporation
11.21.1 SonoScape Medical Corporation Company Details
11.21.2 SonoScape Medical Corporation Business Overview
11.21.3 SonoScape Medical Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.21.4 SonoScape Medical Corporation Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.21.5 SonoScape Medical Corporation Recent Developments
11.22 Shanghai AOHUA Photoelectricity Endoscope Co., Ltd.
11.22.1 Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. Company Details
11.22.2 Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. Business Overview
11.22.3 Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.22.4 Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.22.5 Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. Recent Developments
11.23 Ottomed
11.23.1 Ottomed Company Details
11.23.2 Ottomed Business Overview
11.23.3 Ottomed Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.23.4 Ottomed Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.23.5 Ottomed Recent Developments
11.24 Kimberly-Clark Corporation
11.24.1 Kimberly-Clark Corporation Company Details
11.24.2 Kimberly-Clark Corporation Business Overview
11.24.3 Kimberly-Clark Corporation Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.24.4 Kimberly-Clark Corporation Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.24.5 Kimberly-Clark Corporation Recent Developments
11.25 Shaili Endoscopy
11.25.1 Shaili Endoscopy Company Details
11.25.2 Shaili Endoscopy Business Overview
11.25.3 Shaili Endoscopy Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Introduction
11.25.4 Shaili Endoscopy Revenue in Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Business (2017-2022)
11.25.5 Shaili Endoscopy Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • カウンターUAS（C-UAS）技術の世界市場インサイト・予測（～2028年）
  • フレキシブル内視鏡手術ロボットの世界市場インサイト・予測（～2028年）
  • 内視鏡粘膜下層剥離術器具の世界市場インサイト・予測（～2028年）
  • 内視鏡フラッシングポンプの世界市場インサイト・予測（～2028年）
  • 超音波内視鏡ガイド付き針の世界市場インサイト・予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QY22JL3555 )"内視鏡逆行性胆道膵管造影（ERCP）技術の世界市場インサイト・予測（～2028年）" (英文：Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Technique Market Insights, Forecast to 2028)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。